208046-23-5

Basic information

• Product Name: tert-butyl 4-hydroxy-2-Methylpiperidine-1-carboxylate
• Synonyms: tert-butyl 4-hydroxy-2-Methylpiperidine-1-carboxylate;1-t-Butoxycarbonyl-4-hydroxy-2-methylpiperidine
• CAS NO: 208046-23-5
• Molecular Formula: C₁₁H₂₁NO₃
• Molecular Weight: 215.28934
• Mol File: 208046-23-5.mol
• Article Data: 5

Chemical Properties

• Boiling Point: 301.4±35.0 °C(Predicted)
• Appearance: /
• Density: 1.067±0.06 g/cm3(Predicted)
• PKA: 14.82±0.40(Predicted)
• CAS DataBase Reference: tert-butyl 4-hydroxy-2-Methylpiperidine-1-carboxylate(CAS DataBase Reference)
• NIST Chemistry Reference: tert-butyl 4-hydroxy-2-Methylpiperidine-1-carboxylate(208046-23-5)
• EPA Substance Registry System: tert-butyl 4-hydroxy-2-Methylpiperidine-1-carboxylate(208046-23-5)

Safety Data

• Hazardous Substances Data: 208046-23-5(Hazardous Substances Data)

Usage

General Description

"Tert-butyl 4-hydroxy-2-methylpiperidine-1-carboxylate" is a chemical compound with the molecular formula C12H23NO3. It is commonly used in the pharmaceutical industry as an intermediate in the synthesis of various drugs. tert-butyl 4-hydroxy-2-Methylpiperidine-1-carboxylate is a derivative of piperidine, a heterocyclic amine, and contains a tert-butyl group, a hydroxy group, and a methyl group. It is known for its potential pharmacological properties and has been studied for its potential therapeutic applications. This chemical compound is often used in the creation of medications and drugs for various medical conditions due to its structural properties and reactivity.

Upstream product

• 190906-92-4 tert-butyl 2-methyl-4-oxopiperidine-1-carboxylate 

Downstream Products

• 470477-66-8 4-(1-t-butoxycarbonyl-2-methylpiperidin-4-yloxy)-3-chloronitrobenzene 

Relevant articles and documents

THERAPEUTIC COMPOUNDS

The present invention provides compounds of formula (I) and pharmaceutically acceptable salts thereof in which m, n, W, X, Y, Z, R, R1, R2, R3 and R4 are as defined in the specification, for use in therapy.

PYRIDONE AND PYRIDAZONE ANALOGUES AS GPR119 MODULATORS

Novel compounds of structure Formula (I) or an enantiomer, a diastereomer, or a pharmaceutically acceptable salt thereof, wherein Z, R1, R2, R21, T1, T2, T3 and T4 are defined herein, are provided which are GPR119 G protein-coupled receptor modulators. GPR119 G protein-coupled receptor modulators are useful in treating, preventing, or slowing the progression of diseases requiring GPR119 G protein-coupled receptor modulator therapy. Thus, the disclosure also concerns compositions comprising these novel compounds and methods of treating diseases or conditions related to the activity of the GPR119 G protein-coupled receptor by using any of these novel compounds or a composition comprising any of such novel compounds.

Aminooxy piperidines as ornithine decarboxylase inhibitors

The invention relates to compounds of formula I STR1 wherein either R1 is a radical of formula Ia, in which n is 0 or 1, is hydrogen and R2 is a radical of formula Ib, in which p is 1 or 2, and wherein R is C1 -C2/su